News
YolTech has received FDA approval for its investigational new drug (IND) application for YOLT-101 to treat HeFH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback